La cadena de opciones muestra datos clave de las opciones de acciones de SI-BONE a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para SI-BONE..

SI-BONE (NASDAQ:SIBN) Bolsa, Cadena de Opciones

SI-BONE

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

SI-BONE Inc

Press Releases

General

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Health Care

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Earnings

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Bruker Appoints Laura Francis to its Board of Directors

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

BRKR

PGNY

SWAV

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

ClearPoint Neuro

Conmed

Delcath Systems

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

NeuroPace

Orthofix Medical

Omnicell

Pulse Biosciences

QuidelOrtho

Senseonics Holdings

Semler Scientific

Surmodics

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Varex Imaging

Citizens Capital Markets

Truist Securities

Cantor Fitzgerald

Needham

Morgan Stanley

Comments

SI-BONE

SI-BONE (SIBN) Opciones

SI-BONE (NASDAQ:SIBN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL